- Condition: Chronic Pain
Intervention: Behavioral: Online ABBT for Chronic Pain in Military
Sponsors: University of Manitoba; University of Manitoba
Not yet recruiting - verified April 2012 - Condition: Type 2 Diabetes Mellitus
Intervention: Behavioral: Lifestyle Counselling
Sponsors: University of Manitoba; University of Manitoba; Manitoba Institute of Child Health
Not yet recruiting - verified May 2012 - Conditions: Bradycardia; Desaturation
Interventions: Drug: Provision of atropine; Drug: Placebo
Sponsors: University of Manitoba; University of Manitoba
Recruiting - verified May 2012 - Condition: Muscle Development
Interventions: Dietary Supplement: Whey protein; Dietary Supplement: Chocolate milk; Dietary Supplement: Sugar
Sponsors: University of Manitoba; University of Manitoba
Recruiting - verified April 2012 - Condition: Sitosterolemia
Intervention: Drug: Ezetimibe
Sponsors: University of Manitoba; University of Manitoba
Recruiting - verified April 2012 - Conditions: Obesity; Hypercholesterolemia
Interventions: Other: Consumption of cooked lentils; Other: Consumption of potato-based foods
Sponsors: University of Manitoba; University of Manitoba; Agriculture and Agri-Food Canada
Recruiting - verified March 2012 - Condition: Respiratory Distress Syndrome
Interventions: Device: Angiocath; Device: Vascular catheter 16 G 133 mm length (Angi-Cath)
Sponsors: University of Manitoba; University of Manitoba
Recruiting - verified May 2012 - Condition: Colorectal Cancer
Interventions: Other: Oncology Interactive Navigator; Other: Routine Care
Sponsors: McGill University; McGill University
Recruiting - verified May 2012 - Condition: Complete Edentulism
Intervention: Other: Questionnaire
Sponsors: University of Manitoba; University of Manitoba
Recruiting - verified March 2012 - Condition: Isolated Anterior Cruciate Ligament Rupture
Interventions: Other: Autograft STG harvest from ACL-deficient leg; Other: Autograft harvest contralateral to ACL-deficient leg
Sponsors: Panam Clinic; Panam Clinic
Active, not recruiting - verified February 2012 - Conditions: Fetal Alcohol Spectrum Disorder; Attachment Disorders
Intervention: Behavioral: Circle of Security (COS)
Sponsors: University of Manitoba; University of Manitoba
Not yet recruiting - verified February 2012 - Conditions: Multiple Sclerosis; Fatigue
Interventions: Drug: Testosterone undecanoate; Drug: placebo
Sponsors: Health Sciences Centre, Winnipeg, Manitoba; Health Sciences Centre, Winnipeg, Manitoba; University of Manitoba; Consortium of Multiple Sclerosis Centers; Manitoba Medical Service Foundation
Not yet recruiting - verified January 2012 - Condition: Rotator Cuff Tear
Interventions: Procedure: Rotator Cuff Repair Surgery; Other: Non Operative Treatment
Sponsors: University of Manitoba; University of Manitoba; University of Alberta
Not yet recruiting - verified December 2011 - Condition: Obesity
Interventions: Other: Pulse Group; Other: Active Comparator
Sponsors: University of Manitoba; University of Manitoba; University of South Australia
Not yet recruiting - verified December 2011 - Condition: Acute Respiratory Distress Syndrome (ARDS)
Interventions: Device: SensorMedics 3100B High Frequency Oscillatory Ventilator; Procedure: Lung Protective Ventilation
Sponsors: Canadian Critical Care Trials Group; Canadian Critical Care Trials Group; Canadian Institutes of Health Research (CIHR); McMaster University; University of Toronto
Recruiting - verified January 2010 - Condition: Burn Scar
Intervention: Procedure: pulsed dye laser
Sponsors: University of Manitoba; University of Manitoba
Not yet recruiting - verified December 2011 - Condition: Cardiac Surgery
Interventions: Other: Liberal transfusion triggers; Other: Restrictive transfusion triggers
Sponsors: St. Michael's Hospital, Toronto; Nadine Shehata; Canadian Institutes of Health Research (CIHR); Health Canada
Recruiting - verified May 2012 - Condition: Hypercholesterolemia
Interventions: Dietary Supplement: WD-PS intervention phase; Dietary Supplement: PS-Ester intervention phase; Dietary Supplement: placebo
Sponsors: University of Manitoba; University of Manitoba
Completed - verified December 2011 - Condition: Cardiac Sarcoidosis
Intervention:
Sponsors: University of Ottawa Heart Institute; University of Ottawa Heart Institute; Ontario Ministry of Health and Long Term Care
Not yet recruiting - verified December 2011 - Conditions: Post-operative Pain; Complications
Interventions: Procedure: Defect Unsutured; Procedure: Defect Sutured
Sponsors: St. Paul's Hospital, Canada; Dr. Carl J Brown; Canadian Society of Colon and Rectal Surgeons
Recruiting - verified March 2012 - Condition: Healthy Metabolism
Intervention: Drug: Amantadine
Sponsors: University of Manitoba; University of Manitoba; St. Boniface General Hospital Research Centre
Recruiting - verified November 2011 - Conditions: DIEP Flap Breast Reconstruction; SIEA Flap Breast Reconstruction
Interventions: Procedure: DIEP flap breast reconstruction; Procedure: SIEA flap breast reconstruction
Sponsors: University of Manitoba; University of Manitoba; Keeping Abreast Charity
Recruiting - verified April 2012 - Condition: Prostatic Neoplasms
Interventions: Radiation: Image-guided radiotherapy; Radiation: Image-guided radiotherapy
Sponsors: CancerCare Manitoba; CancerCare Manitoba; Sunnybrook Health Sciences Centre
Recruiting - verified February 2012 - Conditions: Syncope; Heart Block; Conduction Disorder of the Heart
Interventions: Procedure: pacemaker; Procedure: implantable loop recorder
Sponsors: University of Calgary; Canadian Institutes of Health Research (CIHR); Vanderbilt University
Recruiting - verified April 2012 - Condition: Above Optimal Blood Cholesterol
Interventions: Dietary Supplement: Control; Dietary Supplement: Low molecular weight/low viscosity beta-glucan; Dietary Supplement: Low molecular weight/low viscosity beta-glucan; Dietary Supplement: High molecular weight/high viscosity beta glucan
Sponsors: University of Manitoba; University of Manitoba; Agriculture and Agri-Food Canada
Active, not recruiting - verified August 2011 - Conditions: Catheter Related Infection; Bacteremia
Interventions: Other: 30 % ethanol / 4% sodium citrate catheter locking solution; Drug: Heparin 1000 u / ml
Sponsors: University of Manitoba; University of Manitoba
Recruiting - verified July 2011 - Condition: Peripheral Artery Disease
Interventions: Other: control foods; Other: Mixed bean (higher amount); Other: Mixed beans (lower amount)
Sponsors: University of Manitoba; University of Manitoba; Pulse Canada
Recruiting - verified March 2012 - Condition: Mobility Limitation
Intervention: Behavioral: game-based balance exercises
Sponsors: University of Manitoba; University of Manitoba
Completed - verified March 2007 - Condition: Osteoarthritis
Intervention:
Sponsors: Hammond, Allan, M.D.; Hammond, Allan, M.D.
Recruiting - verified June 2011 - Condition: Influenza Vaccine
Interventions: Biological: Agriflu; Biological: Fluad; Biological: Intanza; Biological: Vaxigrip
Sponsors: University of British Columbia; University of British Columbia; PHAC/CIHR Influenza Research Network
Active, not recruiting - verified March 2012 - Conditions: Disease Due to BK Polyomavirus; Kidney Transplant Infection
Intervention: Drug: Levofloxacin
Sponsors: Ottawa Hospital Research Institute; Ottawa Hospital Research Institute; Canadian Institutes of Health Research (CIHR); St. Paul's Hospital, Canada; Vancouver General Hospital; University of Alberta; University of Manitoba; University Health Network, Toronto; St. Michael's Hospital, Toronto; St. Joseph's Healthcare Hamilton; London Health Sciences Centre; McGill University Health Center; Dalhousie University
Recruiting - verified March 2012 - Conditions: Other Instability, Shoulder; Hill-Sachs Lesion
Interventions: Procedure: Bankart repair and remplissage; Procedure: Bankart repair
Sponsors: Panam Clinic; Panam Clinic; University of Ottawa; University of Western Ontario, Canada; University of British Columbia
Recruiting - verified February 2012 - Condition: Metabolic Syndrome
Interventions: Other: Corn and safflower oil; Other: Canola oil; Other: High oleic acid canola oil; Other: DHA enriched high oleic acid canola oil; Other: Flax and safflower oil
Sponsors: University of Manitoba; University of Manitoba; University of Toronto; Penn State University; Laval University
Active, not recruiting - verified September 2011 - Condition: Acute Kidney Injury
Intervention:
Sponsors: Biosite; Biosite
Recruiting - verified February 2012 - Conditions: Neurogenic Bladder; Spina Bifida
Intervention: Device: Intermittent catheterization
Sponsors: University of Alberta; University of Alberta
Recruiting - verified December 2011 - Condition: Peripheral Arterial Disease
Interventions: Other: traditional canola oil; Other: high oleic canola oil; Other: soybean oil; Other: high linoleic safflower oil; Other: coconut oil; Other: traditional canola oil; Other: safflower oil
Sponsors: University of Manitoba; University of Manitoba; St. Boniface General Hospital Research Centre
Recruiting - verified December 2011 - Conditions: Acute Kidney Injury; Abdominal Aortic Aneurysm
Interventions: Drug: curcumin; Other: placebo
Sponsors: Lawson Health Research Institute; Lawson Health Research Institute; Canadian Institutes of Health Research (CIHR)
Recruiting - verified December 2011 - Condition: Muscle Spasticity as a Result of Spinal Cord Injury
Interventions: Drug: nabilone 0.5 mg; Drug: placebo
Sponsors: University of Manitoba; University of Manitoba; The Manitoba Spinal Cord Injury Research Fund; Canadian Paraplegic Association
Not yet recruiting - verified April 2011 - Condition: Gestational Hypertension
Interventions: Procedure: Intervention is blood pressure management approach; Procedure: Intervention is blood pressure management approach.
Sponsors: University of British Columbia; University of British Columbia; Canadian Institutes of Health Research (CIHR); Sunnybrook Research Institute
Recruiting - verified December 2011 - Condition: Suicide
Intervention: Other: ASIST
Sponsors: University of Manitoba; University of Manitoba; American Foundation for Suicide Prevention
Active, not recruiting - verified August 2011 - Conditions: Leukemia; Solid Tumours
Intervention: Drug: SB939
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Active, not recruiting - verified April 2012 - Condition: Melanoma
Interventions: Drug: rIL-21; Drug: Dacarbazine
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Active, not recruiting - verified May 2012 - Condition: Peripheral Arterial Disease
Interventions: Other: Control; Other: Classic Egg Group; Other: Omega 3 Egg Group
Sponsors: University of Manitoba; University of Manitoba
Recruiting - verified December 2011 - Condition: Hyperlipidemia
Interventions: Dietary Supplement: Plant sterol; Dietary Supplement: Placebo
Sponsors: University of Manitoba; University of Manitoba
Completed - verified February 2012 - Condition: Castration Resistant Prostate Cancer
Interventions: Drug: OGX-427 and Prednisone; Drug: Prednisone
Sponsors: British Columbia Cancer Agency; British Columbia Cancer Agency; OncoGenex Technologies, Inc.
Recruiting - verified December 2011 - Conditions: Chronic Obstructive Pulmonary Disease; Nocturnal Desaturation
Interventions: Device: Concentrator; Device: Sham concentrator
Sponsors: Laval University; Laval University; Canadian Institutes of Health Research (CIHR)
Recruiting - verified February 2012 - Conditions: Oral Cancer; High-grade Precancer
Interventions: Procedure: Fluorescence visualization device; Procedure: Fluorescence visualization device
Sponsors: University of British Columbia; University of British Columbia; Terry Fox Research Institute; British Columbia Cancer Agency
Recruiting - verified December 2011 - Conditions: Multiple Myeloma; Lymphoma
Interventions: Drug: Plerixafor; Other: Observation: Nonintervention
Sponsors: CancerCare Manitoba; CancerCare Manitoba
Recruiting - verified February 2012 - Condition: Lumbar Spinal Stenosis
Intervention: Other: Walking program
Sponsors: University of Manitoba; University of Manitoba
Enrolling by invitation - verified August 2011 - Conditions: Nausea and Vomiting; Pain; Sleep Disorders; Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: methadone hydrochloride; Other: questionnaire administration; Procedure: management of therapy complications
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Terminated - verified July 2011 - Condition: Lumbar Herniated Disc
Intervention: Procedure: Microdiscectomy
Sponsors: University of Manitoba; University of Manitoba
Enrolling by invitation - verified August 2011 - Condition: Bone Scan
Intervention: Other: 18F-Sodium Fluoride (Na18F)
Sponsors: Alberta Health Services; Alberta Health Services
Recruiting - verified April 2012 - Condition: Type 2 Diabetes
Intervention: Other: buckwheat, rice crackers, glucose, sugar substitute
Sponsors: St. Boniface General Hospital Research Centre; St. Boniface General Hospital Research Centre; University of Manitoba
Completed - verified March 2012 - Condition: Chronic Kidney Disease
Intervention:
Sponsors: University of British Columbia; University of British Columbia
Active, not recruiting - verified November 2011 - Condition: Head and Neck Cancer
Interventions: Biological: panitumumab; Drug: cisplatin; Radiation: 3-dimensional conformal radiation therapy; Radiation: accelerated radiation therapy; Radiation: intensity-modulated radiation therapy
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Active, not recruiting - verified November 2011 - Conditions: Insomnia; Insomnia Disorder
Intervention: Behavioral: Cognitive Behavioral Therapy
Sponsors: University of Manitoba; University of Manitoba
Active, not recruiting - verified September 2011 - Conditions: Anxiety Disorder; Cognitive/Functional Effects; Colorectal Cancer; Depression; Fatigue; Psychosocial Effects of Cancer and Its Treatment; Sleep Disorders
Interventions: Behavioral: exercise intervention; Other: counseling intervention; Other: educational intervention; Other: laboratory biomarker analysis; Other: questionnaire administration; Other: study of socioeconomic and demographic variables; Procedure: fatigue assessment and management; Procedure: quality-of-life assessment
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Recruiting - verified May 2012 - Condition: Cystic Fibrosis
Interventions: Other: Positive Expiratory Pressure (PEP); Other: High Frequency Chest Wall Oscillation (HFCWO) using InCourage Vest System
Sponsors: University of British Columbia; University of British Columbia; Canadian Cystic Fibrosis Foundation
Active, not recruiting - verified April 2012 - Condition: Hematoma
Interventions: Drug: low molecular weight heparin or unfractionated heparin; Drug: Warfarin or coumadin
Sponsors: University of Ottawa Heart Institute; University of Ottawa Heart Institute; Canadian Institutes of Health Research (CIHR)
Recruiting - verified July 2011 - Condition: Breast Cancer
Interventions: Drug: letrozole; Other: placebo
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group; Eastern Cooperative Oncology Group; North Central Cancer Treatment Group; Southwestern Oncology Group (SWOG); Cancer and Leukemia Group B
Active, not recruiting - verified May 2012 - Condition: Peripheral Arterial Disease
Intervention: Other: Pulses
Sponsors: St. Boniface General Hospital Research Centre; St. Boniface General Hospital Research Centre; University of Manitoba
Completed - verified March 2012 - Conditions: Acute Coronary Syndrome; Myocardial Infarction; Smoking
Interventions: Drug: Bupropion HCl ER; Drug: Placebo
Sponsors: McGill University; Mark Eisenberg; Canadian Institutes of Health Research (CIHR); Heart and Stroke Foundation of Quebec
Completed - verified May 2008 - Condition: Critical Illness
Interventions: Procedure: Protocolized Sedation; Procedure: Protocolized sedation, with daily interruption
Sponsors: Mount Sinai Hospital, Canada; Mount Sinai Hospital, Canada; Canadian Institutes of Health Research (CIHR); Ottawa Hospital Research Institute
Active, not recruiting - verified September 2011 - Conditions: Clinically Isolated Syndromes; Early Single Relapse of Multiple Sclerosis
Interventions: Drug: Apo-Minocycline; Drug: Placebo Comparator
Sponsors: University of Calgary; Dr. Luanne Metz; Multiple Sclerosis Society of Canada
Recruiting - verified March 2012 - Condition: Colorectal Cancer
Interventions: Biological: cetuximab; Drug: brivanib alaninate
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Active, not recruiting - verified May 2012 - Condition: Respiratory Insufficiency of Prematurity
Intervention: Other: Titration of oxygen therapy
Sponsors: McMaster University; McMaster University; Canadian Institutes of Health Research (CIHR)
Active, not recruiting - verified March 2012 - Condition: Brain and Central Nervous System Tumors
Interventions: Drug: temozolomide; Genetic: DNA methylation analysis; Other: laboratory biomarker analysis; Procedure: adjuvant therapy; Procedure: quality-of-life assessment; Radiation: radiation therapy
Sponsors: National Cancer Institute (NCI); European Organization for Research and Treatment of Cancer - EORTC; NCIC Clinical Trials Group; Radiation Therapy Oncology Group; Medical Research Council; Cooperative Trials Group for Neuro-Oncology
Recruiting - verified May 2011 - Condition: Chronic Lymphocytic Leukemia
Intervention: Drug: Valproic acid & fludarabine
Sponsors: CancerCare Manitoba; CancerCare Manitoba; The Leukemia and Lymphoma Society
Terminated - verified July 2011 - Condition: Melanoma (Skin)
Interventions: Biological: recombinant human interleukin-21; Other: immunohistochemistry staining method; Other: laboratory biomarker analysis; Other: pharmacological study
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Active, not recruiting - verified May 2012 - Conditions: Obesity; Gestational Diabetes; Type 2 Diabetes
Intervention: Behavioral: Exercise and dietary education
Sponsors: University of Manitoba; University of Manitoba; The Lawson Foundation
Recruiting - verified August 2011 - Condition: Brain and Central Nervous System Tumors
Interventions: Drug: temozolomide; Genetic: DNA methylation analysis; Procedure: quality-of-life assessment; Radiation: Radiation
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group; European Organization for Research and Treatment of Cancer - EORTC; Trans-Tasman Radiation Oncology Group (TROG)
Recruiting - verified March 2012 - Condition: Respiratory Insufficiency of Prematurity
Interventions: Device: nCPAP; Device: NIPPV
Sponsors: McMaster University; McMaster University; Canadian Institutes of Health Research (CIHR)
Completed - verified March 2012 - Condition: Lymphoma
Interventions: Biological: rituximab; Drug: bortezomib; Drug: cyclophosphamide; Drug: prednisone; Drug: vincristine sulfate
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Completed - verified January 2012 - Condition: Lymphoma
Interventions: Drug: bortezomib; Drug: gemcitabine hydrochloride
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Completed - verified June 2011 - Condition: Lung Cancer
Intervention: Radiation: 3-dimensional conformal radiation therapy
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Active, not recruiting - verified September 2011 - Condition: Prostate Cancer
Interventions: Procedure: 7800 cGy/39 fractions in 8 weeks; Procedure: 6000 cGy/20 fractions in 4 weeks
Sponsors: Ontario Clinical Oncology Group (OCOG); Ontario Clinical Oncology Group (OCOG); Canadian Institutes of Health Research (CIHR); Trans-Tasman Radiation Oncology Group (TROG)
Active, not recruiting - verified October 2011 - Condition: Breast Cancer
Interventions: Radiation: 3D-CRT APBI; Radiation: WBI
Sponsors: Ontario Clinical Oncology Group (OCOG); Ontario Clinical Oncology Group (OCOG); Canadian Institutes of Health Research (CIHR); Canadian Breast Cancer Research Alliance
Active, not recruiting - verified July 2011 - Condition: Venous Ulcer
Interventions: Device: Four-layer Bandage (Elastomeric); Device: Short-stretch Bandage (Non-elastomeric)
Sponsors: Queen's University; Queen's University; Canadian Institutes of Health Research (CIHR)
Completed - verified October 2011 - Condition: Brain and Central Nervous System Tumors
Interventions: Drug: temozolomide; Radiation: radiation therapy
Sponsors: European Organization for Research and Treatment of Cancer - EORTC; European Organization for Research and Treatment of Cancer - EORTC; NCIC Clinical Trials Group; British Medical Research Council; Trans-Tasman Radiation Oncology Group (TROG)
Active, not recruiting - verified February 2012 - Condition: Apnea of Prematurity
Intervention: Drug: Caffeine citrate injection
Sponsors: McMaster University; McMaster University; Canadian Institutes of Health Research (CIHR); National Health and Medical Research Council, Australia
Active, not recruiting - verified March 2012 - Condition: Coronary Artery Disease
Intervention: Procedure: Radial Artery and Saphenous Vein Grafts Randomized to either right coronary or left circumflex coronary artery territories
Sponsors: Sunnybrook Health Sciences Centre; Sunnybrook Health Sciences Centre; Canadian Institutes of Health Research (CIHR)
Completed - verified November 2011 - Condition: Syncope, Vasovagal, Neurally-Mediated
Intervention: Drug: fludrocortisone acetate
Sponsors: University of Calgary; University of Calgary; Canadian Institutes of Health Research (CIHR)
Completed - verified April 2012 - Condition: Breast Cancer
Intervention: Drug: exemestane
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group; Grupo Espanol de Investigacion del Cancer de Mama; UNICANCER
Active, not recruiting - verified August 2011 - Condition: Lymphoma
Interventions: Biological: rituximab; Drug: cisplatin; Drug: cytarabine; Drug: dexamethasone; Drug: gemcitabine hydrochloride; Other: clinical observation
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Recruiting - verified May 2012 - Condition: Breast Cancer
Interventions: Biological: pegfilgrastim; Drug: docetaxel; Drug: epirubicin hydrochloride
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Active, not recruiting - verified September 2011 - Condition: Lymphoma
Interventions: Biological: rituximab; Drug: CHOP regimen
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Active, not recruiting - verified May 2012 - Conditions: Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
Interventions: Drug: carboplatin; Drug: cisplatin; Drug: paclitaxel; Drug: topotecan hydrochloride
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group; European Organization for Research and Treatment of Cancer - EORTC
Active, not recruiting - verified August 2011 - Condition: Pancreatic Cancer
Interventions: Drug: erlotinib hydrochloride; Drug: gemcitabine hydrochloride
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Completed - verified September 2011 - Condition: Breast Cancer
Interventions: Biological: epoetin alfa; Biological: filgrastim; Drug: cyclophosphamide; Drug: doxorubicin hydrochloride; Drug: epirubicin hydrochloride; Drug: fluorouracil; Drug: paclitaxel
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group; North Central Cancer Treatment Group; Southwest Oncology Group
Active, not recruiting - verified May 2012 - Condition: Ovarian Cancer
Interventions: Drug: carboplatin; Drug: gemcitabine hydrochloride
Sponsors: National Cancer Institute (NCI); AGO Study Group; European Organization for Research and Treatment of Cancer - EORTC; NCIC Clinical Trials Group
Active, not recruiting - verified June 2011 - Condition: Brain and Central Nervous System Tumors
Interventions: Drug: temozolomide; Radiation: radiation therapy
Sponsors: National Cancer Institute (NCI); European Organization for Research and Treatment of Cancer - EORTC; NCIC Clinical Trials Group
Active, not recruiting - verified September 2011 - Condition: Lung Cancer
Interventions: Drug: carboplatin; Drug: paclitaxel; Drug: rebimastat
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Completed - verified August 2011 - Condition: Lung Cancer
Interventions: Drug: marimastat; Drug: Placebo
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Completed - verified January 2012 - Conditions: Fallopian Tube Cancer; Ovarian Cancer; Primary Peritoneal Cavity Cancer
Interventions: Drug: carboplatin; Drug: cisplatin; Procedure: conventional surgery; Procedure: neoadjuvant therapy
Sponsors: European Organization for Research and Treatment of Cancer - EORTC; European Organization for Research and Treatment of Cancer - EORTC
Active, not recruiting - verified March 2012 - Condition: Hodgkin Lymphoma
Interventions: Biological: bleomycin sulfate; Drug: dacarbazine; Drug: doxorubicin hydrochloride; Drug: vinblastine; Radiation: radiation therapy
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group; Eastern Cooperative Oncology Group
Completed - verified January 2012 - Condition: Breast Cancer
Interventions: Drug: octreotide acetate; Drug: tamoxifen citrate
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Completed - verified September 2011 - Condition: Ovarian Cancer
Intervention: Drug: ISIS 5132
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Completed - verified September 2011
 |
Join Clinical Trials by University in Manitoba |
